Medtronic, Inc. Stock Nyse
Equities
US5850551061
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
12:21am | Edwards Lifesciences first-quarter profit beats estimates on heart devices strength | RE |
Apr. 23 | Edwards Lifesciences Corporation: The story continues |
Financials (USD)
Sales 2024 * | 32.24B | Sales 2025 * | 33.57B | Capitalization | 105B |
---|---|---|---|---|---|
Net income 2024 * | 4.55B | Net income 2025 * | 5.24B | EV / Sales 2024 * | 3.96 x |
Net Debt 2024 * | 22.3B | Net Debt 2025 * | 21.07B | EV / Sales 2025 * | 3.76 x |
P/E ratio 2024 * |
22.6
x | P/E ratio 2025 * |
19.6
x | Employees | - |
Yield 2024 * |
3.47% | Yield 2025 * |
3.65% | Free-Float | 99.82% |
Latest transcript on Medtronic, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 15-01-25 |
Karen Parkhill
DFI | Director of Finance/CFO | 58 | 16-05-31 |
Gregory Smith
COO | Chief Operating Officer | 60 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Donnelly
BRD | Director/Board Member | 62 | 12-12-31 |
Kendall Powell
BRD | Director/Board Member | 70 | 06-12-31 |
Randall Hogan
BRD | Director/Board Member | 68 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
-2.92% | 185B | |
-5.48% | 66.59B | |
+11.22% | 54.66B | |
+16.74% | 47.78B | |
+4.06% | 41.26B | |
+4.56% | 26.95B | |
+1.64% | 26.37B | |
+12.96% | 24.8B | |
-1.60% | 24.6B |